Aplastic anemia

36,272views

Aplastic anemia

Watch later

Watch later

Airflow, pressure, and resistance
Pulmonary embolism
Pulmonary edema
Pulmonary valve disease
Idiopathic pulmonary fibrosis
Restrictive lung diseases
Respiratory system anatomy and physiology
Regulation of pulmonary blood flow
Lung volumes and capacities
Chronic obstructive pulmonary disease: Clinical sciences
Zones of pulmonary blood flow
Obstructive lung diseases: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Respiratory acidosis
Respiratory alkalosis
Approach to respiratory alkalosis: Clinical sciences
Approach to respiratory acidosis: Clinical sciences
Neonatal respiratory distress syndrome: Clinical sciences
Anatomic and physiologic dead space
Physiological changes during exercise
Guillain-Barré syndrome: Clinical sciences
Aspiration pneumonia and pneumonitis: Clinical sciences
Hypoxia
Sickle cell disease (NORD)
Emphysema
Alpha-thalassemia
Sleep apnea: Clinical sciences
Iron deficiency anemia
Cerebral circulation
Erythropoietin
Intrinsic hemolytic normocytic anemia: Pathology review
Beta-thalassemia
Approach to anemia (underproduction): Clinical sciences
Aplastic anemia
Macrocytic anemia: Pathology review
Autoimmune hemolytic anemia
Iron deficiency anemia: Clinical sciences
Non-hemolytic normocytic anemia: Pathology review
Microcytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Anemia of chronic disease
Vitamin B12 deficiency: Clinical sciences
Approach to jaundice (unconjugated hyperbilirubinemia): Clinical sciences
Vitamin B12 deficiency
Consumptive coagulopathy from massive transfusion: Clinical sciences
Pneumothorax
Pulmonary changes at high altitude and altitude sickness
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Respiratory distress syndrome: Pathology review
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Alveolar gas equation
Diffusion-limited and perfusion-limited gas exchange
Gas exchange in the lungs, blood and tissues
Alveolar surface tension and surfactant
Carbon dioxide transport in blood
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Ventilation-perfusion ratios and V/Q mismatch
Ventilation

Transcript

Watch video only

Aplastic anemia is a pancytopenia, meaning all blood cell lines are decreased - so the term aplastic anemia, which just refers to low red blood cell count, is actually a misnomer.

So with aplastic anemia, there’s actually anemia, as well as leukocytopenia, or low white blood cells, as well as thrombocytopenia, or low platelet levels.

This condition takes many forms, ranging from mild to severe depending on the cause.

Now, blood cells are produced in the bones of the body, mainly in the bones of the pelvis, ribs and sternum, through a process called hematopoiesis.

This process starts in the bone marrow, the innermost portion of bone, where the hematopoietic stem cells reside.

These serve as progenitor cells for all the different cell types found in the blood.

First, hematopoietic stem cells, also called hemocytoblasts, can become lymphoid progenitors or myeloid progenitors.

The lymphoid progenitors can develop into lymphoblasts, which can then differentiate into some white blood cells like T-lymphocytes, B-lymphocytes, or natural killer cells.

The myeloid progenitors can differentiate into erythrocytes, or red blood cells, megakaryocytes, which eventually give rise to platelets, or myeloblasts, which can then become other white blood cells like monocytes, neutrophils, basophils, and eosinophils.

The most common cause of aplastic anemia is autoimmune destruction of hematopoietic stem cells.

The details of this mechanism are not fully understood, but research shows that there are alterations in the immunologic appearance of hematopoietic stem cells because of genetic disorders, or after exposure to environmental agents, like radiation or toxins.

This means that the hematopoietic stem cells start expressing non-self antigens and the immune system subsequently targets them for destruction.

As the immune system destroys hematopoietic stem cells a whole host of complications arise.

Due to the low red blood cell count tissues cannot properly oxygenate so the heart pumps harder to circulate the red blood cells leading to chest pain and shortness of breath.

Low platelet counts lead to an increased risk of bleeding from the most minor injuries and in mucosal areas. Low white blood cells counts lead to the body’s inability to fight off common infections that can lead to sepsis.

Now, there are many causes of aplastic anemia, but the disease is most often idiopathic, or without an identifiable cause.

Definable causes of aplastic anemia include radiation and toxins like insecticides or industrial agents that contain benzene.

Drugs that may cause aplastic anemia include chemotherapeutic agents, anti-seizure medications, antiinflammatory medications like indomethacin, antithyroid medications like propylthiouracil and methimazole, and antibiotics like chloramphenicol and sulfonamides.

Key Takeaways

Aplastic anemia is a rare blood disorder caused by bone marrow failure to produce new blood cells. Even though it's referred to as aplastic anemia, it typically presents with pancytopenia, meaning that all three major blood cell lines - the red blood cells, white blood cells, and platelets are affected.

People with aplastic anemia may experience fatigue, shortness of breath, ecchymoses and mucosal bleeding, and frequent infections pallor Aplastic anemia can be caused by a variety of factors, including exposure to radiation or chemotherapy, viral infections, and autoimmune disorders.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  3. "Current concepts in the pathophysiology and treatment of aplastic anemia" Hematology (2013)
  4. "Aplastic anaemia" Hematology (2013)
  5. "Aplastic Anemia" New England Journal of Medicine (2018)
  6. "Harrison's Principles of Internal Medicine" McGraw-Hill (2004)
  7. "The complex pathophysiology of acquired aplastic anaemia" Clinical & Experimental Immunology (2015)